|
|
||||||||
Department of Physiological Science, University of California, Los Angeles, Los Angeles, California 90095-1527
| |
ABSTRACT |
|---|
|
|
|---|
This study was designed to examine the relationship between diet-induced insulin resistance/hyperinsulinemia, fat cell hypertrophy, and hormone-sensitive lipase (HSL) to elucidate whether an attenuated HSL activity leads to obesity. Female Fischer 344 rats were fed either a low-fat, complex-carbohydrate diet or a high-fat, refined-sugar (HFS) diet for 2 wk, 2 mo, or 6 mo. Adipose tissue morphology and HSL activity as well as plasma free fatty acid and glycerol levels were determined at these times. No differences between groups were seen after 2 wk except the previously reported hyperinsulinemia in the HFS animals. At both 2 and 6 mo, the HFS animals demonstrated adipocyte hypertrophy. Basal and stimulated HSL activities and plasma glycerol were significantly elevated in the HFS group. There was a positive correlation between adipocyte size and HSL activity for both basal and stimulated states. These results demonstrate that an attenuated HSL activity is not observed with the onset of insulin resistance/hyperinsulinemia and therefore does not play a role in the development of obesity.
obesity; glycerol; free fatty acids; propranolol
| |
INTRODUCTION |
|---|
|
|
|---|
IT IS NO SECRET that the oldest and most common metabolic disturbance affecting humans is obesity (58). It has been estimated that the economic burden of illness related to it is greater than $39 billion per annum (18). This figure is undoubtedly on the rise because the prevalence of obesity in both children and adults is increasing (27, 34, 52). Obesity, especially abdominal obesity, is part of a cluster of atherosclerotic risk factors comprising the insulin-resistance syndrome (46). Many investigators (9, 20, 46) believe that insulin resistance is the underlying defect that ultimately leads to hyperinsulinemia, hypertriglyceridemia, hypertension, and obesity. Increased sympathetic nervous system activity has been implicated as another consequence of insulin resistance/hyperinsulinemia (36, 50).
The typical Western diet is very high in fat and sucrose and is considered to be a major factor involved in the development of insulin resistance and obesity. Recently, we have demonstrated in an animal model that insulin resistance precedes the development of obesity when the animals are fed a high-fat, sucrose (HFS) diet (9). The insulin resistance occurred in as little as 2 wk. Many other investigators have demonstrated a similar time course for the development of insulin resistance/hyperinsulinemia in animals fed either a diet high in fat or a diet high in sucrose (17, 29, 57). Oscai et al. (41, 42) have demonstrated in long-term experiments that animals fed ad libitum ate isocaloric amounts of a HFS diet or low-fat, starch diet and yet became obese on the HFS diet. Storlein et al. (57) demonstrated that, after ~4 wk with the caloric intake controlled, the high-fat diet group showed a significant increase in the white adipose tissue weight without a change in body weight compared with the high-carbohydrate group.
A mechanism by which an insulin-resistant/hyperinsulinemic state leads to the develpment of obesity has been previously reviewed by Barnard and Wen (10) and by Eckel et al. (24). Insulin stimulates and catecholamines inhibit the activity of lipoprotein lipase (LPL) in a tissue-specific fashion. It has been demonstrated in animals and humans that skeletal muscle LPL is downregulated in a hyperinsulinemic state, whereas adipose tissue LPL is upregulated (7, 24). The result of these alterations in LPL activity would be the shunting of dietary fat into adipose tissue for storage. Hormone-sensitive lipase (HSL), the rate-limiting enzyme for the breakdown of stored triglycerides, is also exquisitely controlled by both catecholamines and insulin, the former being the major stimulator of activity and the latter being the major physiological inhibitor of HSL activity. In a hyperinsulinemic state, it is possible that the normal response of adipose tissue HSL is attenuated, and this along with the increased LPL activity would favor the net deposition of dietary fat and the development of obesity. However, in established obesity the activity of HSL has been found to be increased in both animals (19, 22) and humans (3, 13). A positive correlation between adiposity and sympathetic nerve activity has been reported in humans (1, 11), which may account for part of this increase in HSL activity observed in obesity.
The present study was therefore designed to quantify the activity of HSL in a time-dependent fashion when animals were raised on a HFS vs. a low-fat, complex-carbohydrate (LFCC) diet. Sudies of basal and stimulated HSL activity were conducted starting at 2 wk on the diets to see whether HSL activity was depressed before fat cell hypertrophy.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals and diets. Inbred female Fischer 344 rats were obtained from Harlan Sprague Dawley (San Diego, CA) at 2 mo of age. Female rats were used because we have previously reported that they develop insulin resistance, hyperinsulinemia, and obesity in response to a high-fat, refined-sugar diet (7-9, 29). The rats were allowed to acclimatize to their new environment for 1 wk before being assigned to either a LFCC diet or a HFS diet. Both diets contained a standard vitamin and mineral mix as described previously (8, 9). Briefly, the percent distribution of calories and caloric density of the LFCC and HFS diets were as follows: 23% protein, 9% fat, 68% starch, 0.0% sucrose, and 13.8 kJ/g for the LFCC vs. 21% protein, 39% fat, 0.0% starch, 40% sucrose, and 19.7 kJ/g for the HFS. The food was prepared in powder form by Purina Mills and was provided ad libitum along with water to the animals, which were housed four per cage with a 12:12-h light-dark cycle at 24-25°C. The University of California at Los Angeles Animal Research Committee approved this protocol.
Adipose tissue histology. A portion of the omental fat pad was rinsed in 0.85% NaCl solution and then placed into a solution of 10% phosphate-buffered Formalin. These adipose tissue samples were then prepared for sectioning and staining with hematoxylin and eosin by transferring the adipose tissue into cassettes for dehydration, infiltration, and embedding in paraffin (53). Sections were sliced at a thickness of 4 µm at three different depths (at least 200 µm apart) within the same tissue sample and fixed to slides. Samples were then observed under the microscope, and video prints were taken for the determination of cell size and number. Direct microscopic observations were made into video prints by using a CODONICS VP-3500 Video Printer attached to a Perceptive Systems Image Analysis System, which uses an Olympus BH2 Microscope as its base apparatus. From the video images taken of the slides, the number of cells within a known area were used to calculate the mean cell volume and mean cell number per gram of tissue. Lemonnier (37) and Ashwell et al. (5) both describe this technique in detail and have determined that a constant correction factor of 1.15 could be used to adjust the apparent cell diameter of fixed cells.
Blood chemistry.
After an overnight fast, the animals were anesthetized with chloral
hydrate (7%, 0.5 ml/100 g body wt), and a blood sample was taken via
cardiac puncture into a syringe containing EDTA as an anticoagulant.
The sample was then centrifuged for 20 min, the plasma was separated,
and the sample was frozen and stored at
70°C until further
analysis. Plasma free fatty acid (FFA) concentrations were determined
enzymatically (Wako Chemicals) from the samples at 2 wk, 2 mo, and 6 mo
in both groups. With use of a Sigma Diagnostic Kit, the plasma glycerol
concentrations were determined by using an enzymatic method as
described previously (8) at the same time points.
Adipocyte HSL activity and glycerol assay.
Samples of omental fat were taken from the abdominal cavity fat depots
in both the HFS and LFCC diet group. The fat pads were rinsed first in
0.85% NaCl solution and then were rinsed three more times in medium
199 solution (Sigma Chemical). The adipose tissue was then patted dry
and weighed so that ~500 mg were added to 2.0 ml of prewarmed
incubation medium (medium 199) and incubated at 37°C for 1 h. There
was a time-dependent increase in lipolysis for >60 min; therefore,
this time period was chosen for the incubations. For the stimulation of
lipolysis, isoproterenol was used, as opposed to epinephrine or other
catecholamines, because it is a pure
-agonist and as such it
illicits the greatest lipolytic response. Isoproterenol produced a
dose-dependent increase in lipolysis, with the maximal response being
at 10
5 M. To measure HSL
activity, glycerol release was measured over 1 h in both the basal
state and in the presence of isoproterenol (10
5 M) so that maximal HSL
responsiveness could be examined, as described by Rodbell (49).
Glycerol was determined enzymatically from the supernatant samples by
using a Sigma Diagnostic Kit. Because adipose tissue has a very low
level of glycerol kinase, only a very small fraction of the glycerol
produced by intracellular lipolysis can be reutilized and converted to
-glycerophosphate for use in triglyceride synthesis (14, 32, 38).
Glycerol release is therefore a valid index of lipolysis and thus of
HSL activity. At the end of the incubation, three aliquots of
infranatant (100 µl each) were removed from each incubation mixture
for the measurement of glycerol.
-blocker. Propranolol (1 mg/kg) was administered interperitoneally in a subgroup
of HFS animals at 2 mo, 20 min before they were killed, to block
sympathetic nervous system activation of HSL. The assay for HSL activity from this group was performed as described above.
Statistical analysis. Data from the experiments were analyzed by using either a Student's t-test or ANOVA followed by a repeated-measures t-test. Reported values are expressed as means ± SE. Statistical significance was accepted at P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Adipose tissue morphology.
Table 1 reveals the effects of diet on
omental adipose tissue characteristics. As can be seen in
Table 1, the HFS animals at 2 wk did not differ significantly in mean
cell volume from the LFCC rats. Accordingly, the difference in mean
cell number (expressed per gram of tissue) did not reach statistical
significance. The adipocytes of the HFS rats at 2 mo were 83.8% more
voluminous than their LFCC counterparts. The mean cell number per gram
of tissue for the LFCC rats was 75.3% greater than that for the HFS rats at 2 mo. Table 1 reveals that the volume of the HFS adipocytes continued to increase after 2 mo, reaching 149.8% of the LFCC rats by
6 mo. The mean cell number per gram of tissue for the HFS rats at 6 mo
decreased again due to the increase in mean cell volume, falling in
number to 40.87% of the LFCC rats. It is interesting to note that the
adipocytes from the LFCC rats did not increase in volume or decrease in
mean cell number per gram of tissue during the 6-mo time period.
|
Plasma glycerol and FFA levels.
As can be seen in Table 2, the plasma FFA
levels were not statistically different between the groups at any time
period. The plasma glycerol levels were not significantly different at 2 wk, but by 2 mo the values in the HFS group were 47.3% greater than
those of the LFCC group. By 6 mo the HFS group had 91.4% higher
glycerol levels than those of the LFCC animals.
|
HSL activity.
In all experiments performed with isoproterenol, the stimulated rate of
lipolysis was significantly greater than the basal rate
(P < 0.01). As shown in Fig.
1, the basal activity for HSL in the HFS
adipocytes at 2 wk did not differ from the activity in the LFCC
adipocytes. The stimulated activity for HSL in the cells at 2 wk,
although significantly increased from basal values, was not
significantly elevated in the HFS group compared with the LFCC group.
At 2 mo, the basal activity of HSL was nearly two times as great in the
HFS adipocytes compared with the LFCC adipocytes. The stimulated rate
for HSL activity in the HFS adipocytes at 2 mo was 1.72 times the rate
of the LFCC adipocytes. The animals at 6 mo showed the same trends as
the animals at 2 mo, but the basal rate of HSL activity in the HFS
cells at 6 mo rose to nearly triple the level found in the LFCC cells
at 6 mo. The stimulated activity of HSL in the HFS cells at 6 mo was
1.71 times greater than the stimulated activity of HSL in the LFCC
cells. Basal and stimulated HSL activities remained unchanged
throughout the 6-mo period for the LFCC rats. HSL activity was highly
correlated with fat cell size for both basal and stimulated conditions
(Fig. 2).
|
|
Propranolol study.
Propranolol was used to determine whether the increased basal rate of
lipolysis in the HFS rats was the result of increased sympathetic
nervous system activity. In the HFS rats at 2 mo, in which HSL activity
had increasd, propranolol injection had no effect on the elevated basal
activity of HSL (2.0 ± 0.2 vs. 1.9 ± 0.2 µmol
glycerol · 106
cells
1 · h
1
for control vs. propranolol, respectively). The
effectiveness of the propranolol was demonstrated because it totally
blocked the isoproterenol-stimulated glycerol release (2.2 ± 0.2 vs. 3.4 ± 0.3 µmol
glycerol · 106
cells
1 · h
1
for propranolol vs. control, respectively).
| |
DISCUSSION |
|---|
|
|
|---|
The primary purpose of this investigation was to determine the effect of a HFS diet on adipose tissue morphology and HSL activity. In the HFS model of diet-induced obesity, we (10) hypothesized that hyperinsulinemia resulting from the HFS diet would initially downregulate HSL activity and ultimately lead to the development of obesity. We and others have reported that insulin resistance/hyperinsulinemia develops within a few weeks after the start of a high-fat and/or refined-sugar diet (9, 28, 45, 47). The results of the present study, however, indicate that basal or maximal-stimulated HSL activities are not attenuated due to hyperinsulinemia. In this study, plasma glycerol levels were not elevated at the 2-wk time point, but the levels were elevated at both 2 and 6 mo in the HFS group compared with the LFCC group. This indicates that there was no change in the rate of lipolysis in vivo after 2 wk despite documented hyperinsulinemia (9). The elevated plasma glycerol levels at 2 and 6 mo in the HFS group indicate increased lipolytic activity, which agrees with the in vitro HSL studies. Furthermore, the results suggest that HSL activity is determined by the size of the adipocyte, because both basal and stimulated rates of lipolysis, expressed per cell, were highly correlated with cell size.
The enlargement of adipose tissue mass seen in obesity may be the result of adipocyte hypertrophy, hyperplasia, or a combination of the two (31, 37, 50, 59). The increase in adipose tissue mass found in the HFS animals at 2 and 6 mo in the present study may have been due to both the documented hypertrophy of existing adipocytes and undocumented hyperplasia because hyperinsulinemia has been shown to cause adipocyte hyperplasia (33). Unfortunately the weight of the fat pads themselves could not be measured, and hence total cell number could not be calculated, because the omental fat pad became too enlarged and undefined to isolate as a distinct depot. Adipocyte size in the animals at 2 wk was not statistically different between the groups; however, by 2 mo on the HFS diets the adipocytes were increased in size by 70%. Thus hypertrophy of the fat mass definitely occurred. We (9) have shown previously that at these time points, 2 wk and 2 mo, there was no detectable difference in whole body fat content or weight even though fat cell hypertrophy was observed at 2 mo in the present study. This observation is in agreement with the 4-wk data of Storlien et al. (57), who used a high-fat diet. In the HFS animals at 6 mo, the omental adipocytes grew to be 150% of the size of the LFCC adipocytes. At this point in time, there was a significant difference in whole body fat (17.6 ± 0.6% LFCC vs. 22.4 ± 1.5% HFS) and body weight (188 ± 1.4 g LFCC vs. 214 ± 3.4 g HFS) between the groups (9).
In agreement with the elevation in plasma glycerol levels are the data that show increased basal and stimulated rates of lipolysis in vitro in the adipose tissue from both the HFS animals at 2 and 6 mo compared with the LFCC animals. The increments in both the basal and stimulated rates of HSL activity were highly correlated to the increases in adipocyte cell volumes found at these time periods, which agrees with earlier studies in both rats (13, 19, 55) and humans (4, 12, 15, 39, 48). It has also been demonstrated that larger fat cells incorporate more glucose label into triglycerides, thus demonstrating that fatty acid reesterification is considerably higher in larger fat cells (12, 13, 54). This could explain why fat cell hypertrophy occurred in the HFS rats despite the increase in HSL activity.
The early development of hyperinsulinemia that occurs as a consequence of the HFS diet would be expected to inhibit the rate of lipolysis in vivo. Our experiments do not support this hypothesis because at 2 wk the plasma glycerol and FFA levels were not significantly reduced in the HFS compared with the LFCC animals. These in vivo findings are in agreement with our in vitro fat depot experiments that showed no reduction in basal or stimulated HSL activity at 2 wk. As for the other time points investigated, the increased rates of lipolysis in vitro are congruent with the increased plasma glycerol levels seen at 2 and 6 mo in the HFS rats.
The fact that we did not find parallel increases in plasma FFA and glycerol levels could have different explanations. First, the FFA could be reesterified, leading to the observed fat cell enlargement as discussed earlier in the DISCUSSION. Second, the FFA may be delivered to the liver for packaging into very-low-density lipoprotein particles, leading to the increase in triglycerides observed with the HFS diet (8, 9). It has been shown that the secretion of triacylglycerols from the liver is stimulated by substrate availability, especially FFAs (16, 23). It has also been shown that apoB secretion is elevated due to the increased availability of FFA (23). Third, the FFA may be delivered to the muscle for use as substrate in the TCA cycle (26, 44). Evidence for this hypothesis has been demonstrated by the decreased respiratory quotients seen in obese patients (6, 25, 26). Finally, the usual long-chain fatty acids are very insoluble in an aqueous medium, and they bind in vivo to serum albumin for transport in the plasma. Serum albumin has three high-affinity, primary binding sites for long-chain fatty acids (30), and the normal molar ratio of FFA to albumin varies between 0.15 and 2 with basal values of 0.5-0.8 in humans (43, 56). This leaves binding sites unoccupied under physiological conditions, and thus an increased release of FFA into the plasma might not be detected by using our enzymatic method for determining FFA.
In both animals (36) and humans (21, 35, 40, 50) it has been reported
that increases in plasma insulin levels caused by carbohydrate feeding
are accompanied by increases in plasma norepinephrine levels. It has
also been demonstrated that a physiological increase in plasma insulin
concentration leads to increased muscle sympathetic activity and nerve
firing rate (1, 2, 11). To determine whether an increased sympathetic
activity was responsible for the increase in fat cell basal lipolytic
activity found in our HFS rats at 2 and 6 mo, we injected the
-adrenergic-receptor blocker propranolol into the rats to see
whether this altered the basal rate of HSL activity. The basal rates of
lipolysis were unaltered in the HFS rats at 2 mo after propranolol
treatment. As evidence that the propranolol did in fact block the
-adrenergic receptor in fat cells as expected, the stimulated rates
of lipolysis were completely inhibited. It is clear from this evidence
that an increased sympathetic activity is not responsible for the
increased rate of basal lipolysis found in the HFS animal model. The
exact factors responsible for the increased HSL activity in the HFS rats remain to be determined. The HSL activity measured in the present
study, especially the hormone-stimulated activity, involves a complex
series of events including receptor binding,
phosphorylation/dephosphorylation, the amount of HSL protein, etc.
However, we did previously report an increase in HSL mRNA in the HFS
rats (7). The stimulus for this increase remains to be determined.
In summary, the results from this study show that a HFS diet, compared with a low-fat, starch diet leads to an increase in HSL activity and fat cell hypertrophy in as little as 2 mo. At 2 wk no difference was observed between the two groups for HSL activity and serum glycerol and FFA despite hyperinsulinemia. These results indicate that the previously reported suppression in HSL activity with an acute exposure to insulin does not lead to chronic suppression of HSL and the development of obesity. The increase in basal and hormone-stimulated activity was not due to an increase in sympathetic nervous system activity but was highly correlated to fat cell size.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by National Institute on Aging Grant AG-07592 and by a grant from the L-B Research/Education Foundation.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: R. J. Barnard, Physiological Science, UCLA, P.O. Box 951527, Los Angeles, CA 90095-1527 (E-mail: jbarnard{at}physci.ucla.edu).
Received 21 December 1998; accepted in final form 15 March 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Anderson, E. A.,
T. W. Balon,
R. P. Hoffman,
C. A. Sinkey,
and
A. L. Mark.
Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans.
Hypertension
19:
621-627,
1992
2.
Anderson, E. A.,
R. P. Hoffman,
T. W. Balon,
C. A. Sinkey,
and
A. L. Mark.
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
J. Clin. Invest.
87:
2246-2252,
1991.
3.
Arner, P.,
C. Marcus,
B. Karpe,
T. Sonnenfeld,
and
P. Blome.
Role of alpha-adrenoceptors for adipocyte size in man.
Eur. J. Clin. Invest.
17:
58-62,
1987[Medline].
4.
Arner, P.,
and
J. Ostman.
Relationship between the tissue level of cyclic AMP and the fat cell size of human adipose tissue.
J. Lipid Res.
19:
613-618,
1978[Abstract].
5.
Ashwell, M.,
P. Priest,
M. Bondoux,
C. Sowter,
and
C. K. McPherson.
Human fat cell sizing-a quick, simple method.
J. Lipid Res.
17:
190-192,
1976[Abstract].
6.
Astrup, A.,
B. Buemann,
P. Western,
S. Toubro,
A. Raben,
and
N. J. Christensen.
Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study.
Am. J. Clin. Nutr.
59:
350-355,
1994
7.
Barnard, R. J.,
J. J. Berger,
J. O. Ong,
and
P. A. Kern.
Adipocyte and muscle changes in response to diet leading to obesity.
Diabetes Res.
33:
213-228,
1998.
8.
Barnard, R. J.,
D. J. Faria,
J. E. Menges,
and
D. A. Martin.
Effects of a high-fat, sucrose diet on serum insulin and related atherosclerotic risk factors in rats.
Atherosclerosis
100:
229-236,
1993[Medline].
9.
Barnard, R. J.,
C. K. Roberts,
S. M. Varon,
and
J. J. Berger.
Diet-induced insulin resistance precedes other aspects of the metabolic syndrome.
J. Appl. Physiol.
84:
1311-1315,
1998
10.
Barnard, R. J.,
and
S. J. Wen.
Exercise and diet in the prevention and control of the metabolic syndrome.
Sports Med.
18:
218-228,
1994[Medline].
11.
Berne, C.,
J. Fagius,
T. Pollare,
and
P. Hjemdahl.
The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects.
Diabetologia
35:
873-879,
1992[Medline].
12.
Bjorntorp, P.,
and
M. Karlsson.
Triglyceride synthesis in human subcutaneous adipose tissue cells of different size.
Eur. J. Clin. Invest.
1:
112-117,
1970[Medline].
13.
Bjorntorp, P.,
and
L. Sjostrom.
The composition and metabolism in vitro of adipose tissue fat cells of different sizes.
Eur. J. Clin. Invest.
2:
78-84,
1972[Medline].
14.
Bortz, W. M.,
P. Paul,
A. C. Haff,
and
W. J. Holmes.
Glycerol turnover and oxidation in man.
J. Clin. Invest.
51:
1537-1546,
1972.
15.
Bray, G. A.,
J. A. Glennon,
L. B. Salans,
E. S. Horton,
E. Danforth, Jr.,
and
E. A. Sims.
Spontaneous and experimental human obesity: effects of diet and adipose cell size on lipolysis and lipogenesis.
Metabolism
26:
739-747,
1977[Medline].
16.
Brindley, D. N.,
and
A. M. Salter.
Hormonal regulation of the hepatic low density lipoprotein receptor and the catabolism of low density lipoproteins: relationship with the secretion of very low density lipoproteins.
Prog. Lipid Res.
30:
349-360,
1991[Medline].
17.
Cohen, A. M.,
and
A. Teitelbaum.
Effect of glucose, fructose, sucrose and starch on lipogenesis in rats.
Life Sci.
7:
23-29,
1968[Medline].
18.
Colditz, G. A.
Economic costs of obesity.
Am. J. Clin. Nutr.
55:
503S-507S,
1992
19.
Dax, E. M.,
J. S. Partilla,
and
R. I. Gregerman.
Mechanism of the age-related decrease of epinephrine-stimulated lipolysis in isolated rat adipocytes: beta-adrenergic receptor binding, adenylate cyclase activity, and cyclic AMP accumulation.
J. Lipid Res.
22:
934-943,
1981[Abstract].
20.
DeFronzo, R. A.,
and
E. Ferrannini.
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
Diabetes Care
14:
173-194,
1991[Abstract].
21.
DeHaven, J.,
R. Sherwin,
R. Hendler,
and
P. Felig.
Nitrogen and sodium balance and sympathetic-nervous-system activity in obese subjects treated with a low-calorie protein or mixed diet.
N. Engl. J. Med.
302:
477-482,
1980[Abstract].
22.
DiGirolamo, M.,
M. D. Howe,
J. Esposito,
L. Thurman,
and
J. L. Owens.
Metabolic patterns and insulin responsiveness of enlarging fat cells.
J. Lipid Res.
15:
332-338,
1974[Abstract].
23.
Dixon, J. L.,
and
H. N. Ginsberg.
Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells.
J. Lipid Res.
34:
167-179,
1993[Abstract].
24.
Eckel, R. H.,
T. J. Yost,
and
D. Jensen.
Alterations in lipoprotein lipase in insulin resistance.
Int. J. Obes.
19, Suppl. 1:
s16-s21,
1995.
25.
Golay, A.,
J. P. Felber,
M. Dusmet,
F. Gomez,
B. Curchod,
and
E. Jequier.
Effect of weight loss on glucose disposal in obese and obese diabetic patients.
Int. J. Obes.
9:
181-191,
1985[Medline].
26.
Golay, A.,
J. P. Felber,
E. Jequier,
R. A. DeFronzo,
and
E. Ferrannini.
Metabolic basis of obesity and noninsulin-dependent diabetes mellitus.
Diabetes Metab. Rev.
4:
727-747,
1988[Medline].
27.
Gortmaker, S. L.,
W. H. Dietz, Jr.,
A. M. Sobol,
and
C. A. Wehler.
Increasing pediatric obesity in the United States.
Am. J. Dis. Child.
141:
535-540,
1987[Abstract].
28.
Grimditch, G. K.,
R. J. Barnard,
E. Sternlicht,
R. H. Whitson,
and
S. A. Kaplan.
Effect of diet on insulin binding and glucose transport in rat sarcolemmal vesicles.
Am. J. Physiol.
252 (Endocrinol. Metab. 15):
E420-E425,
1987
29.
Hallfrisch, J.,
F. Lazar,
C. Jorgensen,
and
S. Reiser.
Insulin and glucose responses in rats fed sucrose or starch.
Am. J. Clin. Nutr.
32:
787-793,
1979
30.
Hamilton, J. A.,
S. Era,
S. P. Bhamidipati,
and
R. G. Reed.
Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin.
Proc. Natl. Acad. Sci. USA
88:
2051-2054,
1991
31.
Johnson, P. R.,
L. M. Zucker,
J. A. Cruce,
and
J. Hirsch.
Cellularity of adipose depots in the genetically obese Zucker rat.
J. Lipid Res.
12:
706-714,
1971[Abstract].
32.
Jungas, R. L.,
and
E. G. Ball.
Studies on the metabolism of adipose tissue. XII. The effects of insulin and epinephrine on free fatty acid and glycerol production in the presence and absence of glucose.
Biochemistry
2:
383-388,
1963.
33.
Kazdova, L.,
and
A. Vrana.
Insulin and adipose tissue cellularity.
Horm. Metab. Res.
2:
117-118,
1970[Medline].
34.
Kuczmarski, R. J.,
K. M. Flegal,
S. M. Campbell,
and
C. L. Johnson.
Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991.
JAMA
272:
205-211,
1994[Abstract].
35.
Landsberg, L.,
and
D. R. Krieger.
Obesity, metabolism, and the sympathetic nervous system.
Am. J. Hypertens.
2:
125S-132S,
1989[Medline].
36.
Landsberg, L.,
and
J. B. Young.
Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity.
Int. J. Obes.
9, Suppl. 2:
63-68,
1985.
37.
Lemonnier, D.
Effect of age, sex, and sites on the cellularity of the adipose tissue in mice and rats rendered obese by a high-fat diet.
J. Clin. Invest.
51:
2907-2915,
1972.
38.
Margolis, S.,
and
M. Vaughan.
Alpha-glycerophosphate synthesis and breakdown in homogenates of adipose tissue.
J. Biol. Chem.
237:
44-48,
1962
39.
Mauriege, P.,
D. Prud'homme,
S. Lemieux,
A. Tremblay,
and
J. P. Despres.
Regional differences in adipose tissue lipolysis from lean and obese women: existence of postreceptor alterations.
Am. J. Physiol.
269 (Endocrinol. Metab. 32):
E341-E350,
1995
40.
O'Dea, K.,
M. Esler,
P. Leonard,
J. R. Stockigt,
and
P. Nestel.
Noradrenaline turnover during under- and over-eating in normal weight subjects.
Metabolism
31:
896-899,
1982[Medline].
41.
Oscai, L. B.,
M. M. Brown,
and
W. C. Miller.
Effect of dietary fat on food intake, growth and body composition in rats.
Growth
48:
415-424,
1984[Medline].
42.
Oscai, L. B.,
W. C. Miller,
and
D. A. Arnall.
Effects of dietary sugar and of dietary fat on food intake and body fat content in rats.
Growth
51:
64-73,
1987[Medline].
43.
Potter, B. J.,
D. Sorrentino,
and
P. D. Berk.
Mechanisms of cellular uptake of free fatty acids.
Annu. Rev. Nutr.
9:
253-270,
1989[Medline].
44.
Randle, P. J.,
P. B. Garland,
C. N. Hales,
and
E. A. Newsholme.
The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.
Lancet
1:
785-789,
1963[Medline].
45.
Reaven, G. M.
Banting lecture 1988. Role of insulin resistance in human disease.
Diabetes
37:
1595-1607,
1988[Abstract].
46.
Reaven, G. M.
Effects of differences in amount and kind of dietary carbohydrate on plasma glucose and insulin responses in man.
Am. J. Clin. Nutr.
32:
2568-2578,
1979
47.
Reiser, S.,
H. B. Handler,
L. B. Gardner,
J. G. Hallfrisch,
O. E. T. Michaelis,
and
E. S. Prather.
Isocaloric exchange of dietary starch and sucrose in humans. II. Effect on fasting blood insulin, glucose, and glucagon and on insulin and glucose response to a sucrose load.
Am. J. Clin. Nutr.
32:
2206-2216,
1979
48.
Reynisdottir, S.,
H. Wahrenberg,
K. Carlstrom,
S. Rossner,
and
P. Arner.
Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors.
Diabetologia
37:
428-435,
1994[Medline].
49.
Rodbell, M.
Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis.
J. Biol. Chem.
239:
375-380,
1964
50.
Rowe, J. W.,
J. B. Young,
K. L. Minaker,
A. L. Stevens,
J. Pallotta,
and
L. Landsberg.
Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.
Diabetes
30:
219-225,
1981[Medline].
51.
Schemmel, R.,
O. Mickelsen,
and
J. L. Gill.
Dietary obesity in rats: body weight and body fat accretion in seven strains of rats.
J. Nutr.
100:
1041-1048,
1970.
52.
Shear, C. L.,
D. S. Freedman,
G. L. Burke,
D. W. Harsha,
L. S. Webber,
and
G. S. Berenson.
Secular trends of obesity in early life: the Bogalusa Heart Study.
Am. J. Public Health
78:
75-77,
1988
53.
Sheehan, D.,
and
B. Hrapchak.
Theory and Practice of Histotechnology. St. Louis, MO: Mosby, 1980.
54.
Smith, U.
Effect of cell size on lipid synthesis by human adipose tissue in vitro.
J. Lipid Res.
12:
65-70,
1971[Abstract].
55.
Smith, U.,
J. Kral,
and
P. Bjorntorp.
Influence of dietary fat and carbohydrate on the metabolism of adipocytes of different size in the rat.
Biochim. Biophys. Acta
337:
278-285,
1974[Medline].
56.
Spector, A. A.
Fatty acid binding to plasma albumin.
J. Lipid Res.
16:
165-179,
1975[Abstract].
57.
Storlien, L. H.,
D. E. James,
K. M. Burleigh,
D. J. Chisholm,
and
E. W. Kraegen.
Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats.
Am. J. Physiol.
251 (Endocrinol. Metab. 14):
E576-E583,
1986
58.
Wilber, J. F.
Neuropeptides, appetite regulation, and human obesity.
JAMA
266:
257-259,
1991[Medline].
59.
Zaragoza, N.,
and
J. P. Felber.
Studies on the metabolic effects induced in the rat by a high fat diet. I. Carbohydrate metabolism in vivo.
Horm. Metab. Res.
2:
323-329,
1970[Medline].
This article has been cited by other articles:
![]() |
M. E. Hafidi, I. Perez, J. Zamora, V. Soto, G. Carvajal-Sandoval, and G. Banos Glycine intake decreases plasma free fatty acids, adipose cell size, and blood pressure in sucrose-fed rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1387 - R1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Petersen, C. Jorgensen, A. C. Rustan, L. Froyland, K. Muller-Decker, G. Furstenberger, R. K. Berge, K. Kristiansen, and L. Madsen Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases J. Lipid Res., December 1, 2003; 44(12): 2320 - 2330. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Kraemer and W.-J. Shen Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis J. Lipid Res., October 1, 2002; 43(10): 1585 - 1594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshikawa, H. Shimoda, N. Nishida, M. Takada, and H. Matsuda Salacia reticulata and Its Polyphenolic Constituents with Lipase Inhibitory and Lipolytic Activities Have Mild Antiobesity Effects in Rats J. Nutr., July 1, 2002; 132(7): 1819 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Soria, M. E. D'Alessandro, and Y. B. Lombardo Duration of feeding on a sucrose-rich diet determines metabolic and morphological changes in rat adipocytes J Appl Physiol, November 1, 2001; 91(5): 2109 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Youngren, J. Paik, and R. J. Barnard Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats J Appl Physiol, November 1, 2001; 91(5): 2240 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meijssen, M. C. Cabezas, C. G. M. Ballieux, R. J. Derksen, S. Bilecen, and D. W. Erkelens Insulin Mediated Inhibition of Hormone Sensitive Lipase Activity in Vivo in Relation to Endogenous Catecholamines in Healthy Subjects J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4193 - 4197. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Roberts, N. D. Vaziri, K. H. Liang, and R. J. Barnard Reversibility of Chronic Experimental Syndrome X by Diet Modification Hypertension, May 1, 2001; 37(5): 1323 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Morimoto, K. Kameda, T. Tsujita, and H. Okuda Relationships between lipolysis induced by various lipolytic agents and hormone-sensitive lipase in rat fat cells J. Lipid Res., January 1, 2001; 42(1): 120 - 127. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |